Skip to main content
. 2018 Dec 18;17(3):1825–1830. doi: 10.3892/etm.2018.7108

Table III.

Remission rates of patients with IMN following immunosuppressive therapy.

Remission status, no. of patients (%)

Group Complete remission Partial remission No remission
CTX (n=36) 12 (33.3) 20 (55.6) 4 (11.1)
FK506 (n=20)   4 (20.0) 16 (80.0) 0 (0.0)
All patients (n=56) 16 (28.6) 36 (64.3) 4 (7.1)

CTX, cyclophosphamide; FK506, tacrolimus.